BSX vs. GKOS: Boston Scientific vs. Glaukos Stock Comparison
How do Boston Scientific (BSX) and Glaukos (GKOS) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and Glaukos (GKOS) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | BSX | GKOS |
|---|---|---|
| Name | Boston Scientific Corp. | Glaukos Corp. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 61.96 billion USD | 13.28 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | May 19, 1992 | June 25, 2015 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | GKOS |
|---|---|---|
| Total Return (1Y) | -55.98% | 179.91% |
| Total Return (3Y, Annualized) | -5.05% | 55.51% |
| Total Return (5Y, Annualized) | 0.57% | 35.14% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BSX | GKOS |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 61.24% |
| Beta (5Y) | 0.57 | 0.68 |
| Max Drawdown (5Y) | -61.55% | -53.68% |
| Avg. Volume (3M) | 19.73M | 1.15M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | GKOS |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | 2.87 |
| Sortino Ratio (1Y) | -1.80 | 5.93 |
Profitability
ROE (TTM)
Glaukos (GKOS) reports a negative ROE of -22.84%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Boston Scientific (BSX) reports 14.12%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
GKOS
Health Care Equipment & Services industry group
-22.84%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- GKOS
- -22.84%
- Min
- -47.01%
Net Margin (TTM)
Glaukos (GKOS) reports a negative net margin of -24.60%, usually indicating a net loss over the period. Meanwhile Boston Scientific (BSX) reports 16.62%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
GKOS
Health Care Equipment & Services industry group
-24.60%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- GKOS
- -24.60%
- Min
- -28.46%
Operating Margin (TTM)
Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of Glaukos (GKOS) at 0.39%, which runs around its industry’s norm.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
GKOS
Health Care Equipment & Services industry group
0.39%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- GKOS
- 0.39%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | GKOS |
|---|---|---|
| ROE (TTM) | 14.12% | -22.84% |
| ROA (TTM) | 5.87% | -3.90% |
| Net Margin (TTM) | 16.62% | -24.60% |
| Operating Margin (TTM) | 19.05% | 0.39% |
| Gross Margin (TTM) | 67.98% | 81.13% |
Growth
Revenue Growth
Glaukos (GKOS) at 32.33% sits in the top revenue growth quartile, while Boston Scientific (BSX) at 19.87% is closer to the peer norm — faster top-line expansion for GKOS.
EPS Growth
Only one side can be read here: Boston Scientific (BSX) reports EPS growth of 55.20%, ranked against its industry; Glaukos (GKOS) has no EPS growth figure this period.
Growth Metrics
| Metric | BSX | GKOS |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 32.33% |
| Revenue Growth (3Y CAGR) | 16.54% | 21.51% |
| EPS Growth (YoY) | 55.20% | -- |
| EPS Growth (3Y CAGR) | 62.75% | -- |
Financial Strength
Current Ratio (MRQ)
Glaukos (GKOS) at 4.57 carries current ratio above its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
GKOS
Health Care Equipment & Services industry group
4.57
- Max
- 7.59
- GKOS
- 4.57
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Glaukos (GKOS) at 0.15 keeps leverage in the lower industry quartile, while Boston Scientific (BSX) at 0.46 runs a more typical debt-to-equity mix.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
GKOS
Health Care Equipment & Services industry group
0.15
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- GKOS
- 0.15
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | GKOS |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 4.57 |
| Debt / Equity (MRQ) | 0.46 | 0.15 |
| Net Debt / EBITDA | 2.04 | -- |
Dividends
Dividend Yield (TTM)
Neither Boston Scientific (BSX) nor Glaukos (GKOS) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Boston Scientific (BSX) nor Glaukos (GKOS) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | GKOS |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Boston Scientific (BSX) trades at 18.04 times trailing earnings, ranked against its peers, while Glaukos (GKOS) has no P/E ratio this period.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
GKOS
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GKOS
- --
P/S Ratio (TTM)
Boston Scientific (BSX) at 2.94 prices around its industry’s typical P/S ratio, while Glaukos (GKOS) at 19.24 clears its benchmark range — GKOS looks notably rich on sales.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
GKOS
Health Care Equipment & Services industry group
19.24
- GKOS
- 19.24
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Boston Scientific (BSX) at 2.42 sits near its industry’s typical P/B ratio, while Glaukos (GKOS) at 18.51 prices above its benchmark range — GKOS looks rich relative to book.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
GKOS
Health Care Equipment & Services industry group
18.51
- GKOS
- 18.51
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BSX | GKOS |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | -- |
| P/S Ratio (TTM) | 2.94 | 19.24 |
| P/B Ratio (MRQ) | 2.42 | 18.51 |
| Free Cash Flow Yield (TTM) | 4.02% | 0.40% |